Posts filed under: Neurology & Neurovascular

Soterix Medical Receives ANVISA Medical Device Approval in Brazil for Neuromodulation Products Including PainX and Depression-LTE Treatment

Soterix Medical, Inc. (SMI) recently announced that it had received Brazil’s National Health Surveillance Agency (ANVISA) approval for its products. This approval allows Soterix Medical to immediately begin marketing its products based on its proprietary transcranial Direct Current Stimulation (tDCS)...
Continue Reading →

Penumbra, Medtronic Lead Europe Mechanical Thrombectomy Market Fueled by Favorable Clinical Trials for the Treatment of Ischemic Stroke

The European mechanical thrombectomy market will experience significant growth in unit sales due to new technology and improved clinical outcomes...
Continue Reading →

Favorable Reimbursement Drives European Neuromodulation Device Market

Neuromodulation is the most lucrative sector in the Europe neurological device market, accounting for over half of the revenue. The largest sector of the neuromodulation market is spinal cord stimulators, and it will continue to produce the largest revenue over...
Continue Reading →

Normoglycaemia Key to Improved Neurological Outcome After Paediatric Stroke

Achieving normal blood glucose concentrations may be important in preventing poor neurological outcomes in children following acute arterial ischemic stroke, a review indicates....
Continue Reading →

8th Annual Symposium on Neurovascular Disease 2016

The symposium will focus on existing and emerging therapies for patients with cerebrovascular disease, including management and prevention of ischemic stroke, the latest in endovascular and surgical aneurysm treatment, and strategies for optimizing acute stroke assessment and care....
Continue Reading →

Thank you!

CLOSE

Login

Sign Up

or Login

×